Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F. Fahrmann, Samir Hanash, Kim‐Anh Do et al.|Gastroenterology|2020Cited by 199
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody V. Vykoukal, Timothy C. Thompson, Johannes F. Fahrmann et al.|Nature Communications|2020Cited by 83
Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cellsStacey L. Borrego, Peter Kaiser, Johannes F. Fahrmann et al.|Cancer & Metabolism|2016Cited by 78
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationMarta Sans, Johannes F. Fahrmann|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 7
Vesicle-mediated mitochondrial clearance underlies an actionable metabolic vulnerability in triple-negative breast cancerJody Vykoukal, Johannes F. Fahrmann|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1